ABSTRACT Aims To systematically review and quantitatively synthesize within‐group changes in skeletal muscle strength following semaglutide treatment in adults. Materials and Methods This PRISMA 2020 systematic review was registered in PROSPERO (CRD420251185935).
Luís Guilherme Machado +9 more
wiley +1 more source
Statement of Retraction. Shuangxi Wang, Jian Xu, Ping Song, Benoit Viollet, and Ming-Hui Zou. In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I. Diabetes 2009;58:1893-1901. DOI: 10.2337/db09-0267. PMID: 19528375. PMCID: PMC2712774. [PDF]
American Diabetes Association.
europepmc +1 more source
Using 1H NMR metabolomics, we measured polar and lipid metabolites from human blood neutrophils from people with frailty (n = 31, mean age 84Y), people with rheumatoid arthritis (n = 16, mean age 55Y), robust older (n = 24, mean age 66Y) and healthy younger people (n = 21, mean age 22Y).
Genna Ali Abdullah +5 more
wiley +1 more source
Rab10 Promotes Atlastin-Mediated Endoplasmic Reticulum Membrane Fusion. [PDF]
Kim M +6 more
europepmc +1 more source
RNF13 regulates the endolysosomal pathway through interaction with the small GTPase Arl8B
The E3 ubiquitin ligase RNF13 functions as a regulatory scaffold, organizing Arl8B‐dependent complexes and tuning downstream signaling that controls endolysosomal organization and trafficking. In this model, wild‐type RNF13 associates with Arl8B on endolysosomes, whereas Arl8B (E22D/F55A) or RNF13 (L244A) variants weaken complex assembly, potentially ...
Audrey M. Sénécal +4 more
wiley +1 more source
New Biochemical Insights into RIT GTPases Regulation and Membrane Interactions. [PDF]
Mirzaiebadizi A +6 more
europepmc +1 more source
Epigenetic control of cellular plasticity in breast cancer progression
Cancer cells undergo cell state transitions, termed plasticity, driving cancer progression and dictating therapeutic response. We define breast cancer plasticity into four interconnected processes: (1) breast cancer stem cell fates, (2) epithelial‐to‐mesenchymal transition, (3) maintenance of luminal identity, and (4) acquisition of therapeutic ...
Ellie J. Massey +2 more
wiley +1 more source
The Role of KRAS in Non-Small Cell Lung Cancer: From Molecular Background to Precision Medicine. [PDF]
Gaździcka J, Gołąbek K.
europepmc +1 more source
KRAS signaling networks, mutational heterogeneity, and emerging therapeutic strategies for cancer treatment. [PDF]
Jin S +5 more
europepmc +1 more source
Tubulin flux at spastin-induced nanodamage sites regulates microtubule rescue frequency and EB1 lifetimes. [PDF]
Szczesna E +5 more
europepmc +1 more source

